CytoSorbents Corporation (CTSO)

[BuyMyAsk]

I agree Chris. FDA approval for this will be difficult. I believe that is why they are going for cardiac surgery instead of sepsis. They already have essentially 2 failed trials that couldn't prove the device helped people survive who had sepsis. They could not afford to have a 3rd trial fail with the FDA. It would send the stock to the floor.

I am baffled at todays PR and Dr. Chan STILL SAYING they are going to uplist to a national exchange later this year. They have around 6 months left. The cost of uplist annually is a huge expense for the company. If they do a 20/1 reverse split and the stock is able to get shorted the hedge funds will eat this thing alive. It would be the worst thing Dr. Chan could do at this point. You should never uplist if the fundamentals arent in place.